Brilliant Violet 785TM anti-mouse CD45.2 [104]

BioLegend Inc. has been awarded a contract by the University of Virginia to supply Brilliant Violet 785™ anti-mouse CD45.2 monoclonal antibodies. The contract was executed on September 19, 2026, in Virginia. The line item specifies a unit price of $1 per unit, with the delivery location designated as the Buyer's facility. The specific annual contract value, total contract amount, and cumulative value were not disclosed in the available contract documentation.

The contract deliverable consists of fluorescently labeled monoclonal antibodies utilized in flow cytometry applications for immunological research. These reagents are essential laboratory tools for detecting and analyzing CD45.2 surface antigens on murine immune cells. While the complete contract performance period, specific delivery schedule, and total quantity of units were not specified in the materials provided, the award represents a research supply agreement between the University of Virginia and the prime contractor for the provision of specialized laboratory reagents.